ASX:HLS

Healius Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume2.33 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield2.73%

BetaN/A

Receive HLS News and Ratings via Email

Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter.

About Healius

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services. The company also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin, cancer removal, IVF egg collection, and gynaecological surgery services. It operates 2,234 pathology sites; 15 day hospital sites; and 146 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in St Leonards, Australia.

Healius (ASX:HLS) share price higher on acquisition and rebrand news
July 11, 2021 | msn.com

2 ASX healthcare shares analysts rate highly
July 6, 2021 | fool.com.au

Healius (ASX:HLS) share price pushes higher on solid Q3 update
May 4, 2021 | msn.com

Healius Limited (HLS.AX)
March 26, 2021 | finance.yahoo.com

The Healius (ASX:HLS) share price receives a boost
February 23, 2021 | msn.com

Healius share price on watch as FY20 results hit guidance
August 20, 2020 | fool.com.au

The ASX stocks that could enjoy a consensus earnings upgrade this reporting season
August 10, 2020 | msn.com

3 ASX 200 dividend shares you can buy now and never look back
July 29, 2020 | www.msn.com

Healius share price soars 20% on news of $500 million sale
June 15, 2020 | www.fool.com.au

Australia's Healius to sell primary care business to BGH for $342 mln
June 15, 2020 | www.nasdaq.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Care
Sub-IndustryN/A
SectorMedical
Current SymbolASX:HLS
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.primaryhealthcare.com.au
Phone61 2 9432 9400
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$1.73 billion
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow12.26
Book ValueA$3.22 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.10 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Healius.

4.7 Community Rank

Outperform Votes
Healius has received 17 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Healius has received 7 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Healius has received 70.83% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Healius and other stocks. Vote “Outperform” if you believe HLS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HLS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Healius pays a meaningful dividend of 2.73%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Healius does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Healius insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Growth Ratio
Healius has a PEG Ratio of 3.44. PEG Ratios above 1 indicate that a company could be overvalued.

See Top Rated MarketRank™ Stocks Here

Healius (ASX:HLS) Frequently Asked Questions

What stocks does MarketBeat like better than Healius?

Wall Street analysts have given Healius a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Healius wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Healius' next earnings date?

Healius is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for Healius.

How were Healius' earnings last quarter?

Healius Limited (ASX:HLS) issued its earnings results on Friday, February, 15th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.06.
View Healius' earnings history.

How often does Healius pay dividends? What is the dividend yield for Healius?

Healius announced a Interim dividend on Thursday, February 25th. Shareholders of record on Wednesday, April 14th will be paid a dividend of 0.065 per share on Wednesday, April 14th. This represents a yield of 1.57%. The ex-dividend date is Wednesday, March 24th. This is a positive change from Healius's previous Interim dividend of A$0.03.
View Healius' dividend history.

Is Healius a good dividend stock?

Healius pays an annual dividend of A$0.13 per share and currently has a dividend yield of 2.73%.
View Healius' dividend history.

Who are Healius' key executives?

Healius' management team includes the following people:

Dr. Malcolm W. Parmenter B.S., M.A.I.C.D., M.S., MD, CEO & Director (Age 66, Pay $1.64M)
Ms. Maxine Jacquet, Chief Financial Officer
Mr. Dean Lewsam, Chief Exec. of Imaging
Mr. John McKechnie, Chief Exec. of the Pathology Division
Mr. Peter Wilson, Group Exec. of People & Shared Services (Age 61)
Mr. Ben Korst, CEO of Montserrat Day Hospitals
Mr. Charles Tilley B.Sc., FCIS, L.L.B., B.Sc. (Hons), LLB (Hons), Company Sec.
Ms. Alison Stephenson, Additional Company Sec.
Ms. Janet Payne, Group Exec. of Corp. Affairs
Dr. John Houston, Advisor

Who are some of Healius' key competitors?

Some companies that are related to Healius include (PHGI) (PHGI), American Shared Hospital Services (AMS), Brain Resource (BRC), Cambian Group (CMBN), Champion Pain Care (CPAI), Encompass Health (EHC), Konekt (KKT), Medical Facilities (MFCSF), Pacific Smiles Group (PSQ), Ramsay Health Care (RMSYF), RHÖN-KLINIKUM Aktiengesellschaft (RKAGY), Sonic Healthcare (SKHHY), Sonic Healthcare (SKHCF), Sonic Healthcare (SHL) and Virtus Health (VRT).
View all of HLS's competitors.

What other stocks do shareholders of Healius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healius investors own include BetaShares Crude Oil Index ETF Currency Hedged (Synthetic) (OOO), Neometals (NMT), Magellan High Conviction Trust (MHH), Helloworld Travel (HLO), Flight Centre Travel Group (FLT), Beach Energy (BPT), Bank of Queensland (BOQ), Australis Oil & Gas (ATS), Australia and New Zealand Banking Group (ANZ) and Aeris Environmental (AEI).

What is Healius' stock symbol?

Healius trades on the ASX under the ticker symbol "HLS."

How much money does Healius make?

Healius has a market capitalization of $0.00 and generates $1.73 billion in revenue each year.

How many employees does Healius have?

Healius employs 12,500 workers across the globe.

What is Healius' official website?

The official website for Healius is www.primaryhealthcare.com.au.

How can I contact Healius?

The company can be reached via phone at 61 2 9432 9400.

This page was last updated on 8/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Healius Stock Forecast, Price & News

About Healius

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment